Skip to main content
Premium Trial:

Request an Annual Quote

Highmark Health Evaluating Utility of YouScript Medication Prescribing Software

NEW YORK (GenomeWeb) – Highmark Health announced today that it has agreed to evaluate the utility of YouScript's Precision Prescribing Software, which is designed for safer, more targeted prescribing of medications for patients taking multiple drugs.

The evaluation will be conducted through Highmark's VITAL Innovation Program, a test-and-learn platform that facilitates real-world testing of early-stage medical innovations to produce evidence related to patient experience, and clinical and financial outcomes, Highmark said.

Premier Medical Associates of Pittsburgh, an Allegheny Health Network affiliate, will use YouScript's software in a population of 3,000 patients who take multiple prescriptions by integrating the tool within its electronic health record system. Based on results reported through YouScript, Premier's clinicians will then determine if they can advise patients on their risk of gene-based adverse drug events, and if so, recommend pharmacogenetic testing to optimize the patient's drugs and doses.

The genetic testing for the evaluation of this precision medicine platform is being provided through YouScript-partnered CLIA-accredited laboratory Genelex, Highmark added.

"Patient safety and drug efficacy are paramount for providing high-quality healthcare," Sarah Ahmad, senior vice president of innovation and transformation for Highmark Health, said in a statement. "Through the VITAL program, we are further evaluating YouScript's promising technology for pinpointing patients who may suffer adverse drug interactions that can be avoided by managing their prescriptions and dosages with greater precision."

VITAL's evaluation of YouScript will conclude in December.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.